{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:46:51Z","timestamp":1770742011254,"version":"3.49.0"},"reference-count":44,"publisher":"Japanese Circulation Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2020,6,25]]},"DOI":"10.1253\/circj.cj-19-1102","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T22:04:56Z","timestamp":1591740296000},"page":"1163-1172","source":"Crossref","is-referenced-by-count":13,"title":["Pristane\/Hypoxia (PriHx) Mouse as a Novel Model of Pulmonary Hypertension Reflecting Inflammation and Fibrosis"],"prefix":"10.1253","volume":"84","author":[{"given":"Hiroyoshi","family":"Mori","sequence":"first","affiliation":[{"name":"Department of Vascular Physiology, National Cerebral and Cardiovascular Center Research Institute"},{"name":"Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Ishibashi","sequence":"additional","affiliation":[{"name":"Department of Vascular Physiology, National Cerebral and Cardiovascular Center Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadakatsu","family":"Inagaki","sequence":"additional","affiliation":[{"name":"Department of Vascular Physiology, National Cerebral and Cardiovascular Center Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Okazawa","sequence":"additional","affiliation":[{"name":"Department of Vascular Physiology, National Cerebral and Cardiovascular Center Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Masaki","sequence":"additional","affiliation":[{"name":"Department of Vascular Physiology, National Cerebral and Cardiovascular Center Research Institute"},{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryotaro","family":"Asano","sequence":"additional","affiliation":[{"name":"Department of Vascular Physiology, National Cerebral and Cardiovascular Center Research Institute"},{"name":"Department of Advanced Medical Research for Pulmonary Hypertension, National Cerebral and Cardiovascular Center Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Manabe","sequence":"additional","affiliation":[{"name":"Department of Vascular Physiology, National Cerebral and Cardiovascular Center Research Institute"},{"name":"Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Ohta-Ogo","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Narazaki","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine"},{"name":"Department of Advanced Clinical and Translational Immunology, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatsue","family":"Ishibashi-Ueda","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kumanogoh","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Nakaoka","sequence":"additional","affiliation":[{"name":"Department of Vascular Physiology, National Cerebral and Cardiovascular Center Research Institute"},{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Rabinovitch M. Molecular pathogenesis of pulmonary arterial hypertension. <i>J Clin Invest<\/i> 2012; 122: 4306\u20134313.","DOI":"10.1172\/JCI60658"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Stacher E, Graham BB, Hunt JM, Gandjeva A, Groshong SD, McLaughlin VV, et al. Modern age pathology of pulmonary arterial hypertension. <i>Am J Respir Crit Care Med<\/i> 2012; 186: 261\u2013272.","DOI":"10.1164\/rccm.201201-0164OC"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Humbert M, Monti G, Brenot F, Sitbon O, Portier A, Grangeot-Keros L, et al. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. <i>Am J Respir Crit Care Med<\/i> 1995; 151: 1628\u20131631.","DOI":"10.1164\/ajrccm.151.5.7735624"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Steiner MK, Syrkina OL, Kolliputi N, Mark EJ, Hales CA, Waxman AB. Interleukin-6 overexpression induces pulmonary hypertension. <i>Circ Res<\/i> 2009; 104: 236\u2013244, 228p following 244.","DOI":"10.1161\/CIRCRESAHA.108.182014"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hashimoto-Kataoka T, Hosen N, Sonobe T, Arita Y, Yasui T, Masaki T, et al. Interleukin-6\/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension. <i>Proc Natl Acad Sci USA<\/i> 2015; 112: E2677\u2013E2686.","DOI":"10.1073\/pnas.1424774112"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Savale L, Tu L, Rideau D, Izziki M, Maitre B, Adnot S, et al. Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice. <i>Respir Res<\/i> 2009; 10: 6.","DOI":"10.1186\/1465-9921-10-6"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Mathai SC, Hassoun PM. Pulmonary arterial hypertension in connective tissue diseases. <i>Heart Fail Clin<\/i> 2012; 8: 413\u2013425.","DOI":"10.1016\/j.hfc.2012.04.001"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Rubenfire M, Huffman MD, Krishnan S, Seibold JR, Schiopu E, McLaughlin VV. Survival in systemic sclerosis with pulmonary arterial hypertension has not improved in the modern era. <i>Chest<\/i> 2013; 144: 1282\u20131290.","DOI":"10.1378\/chest.12-0653"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Dorfmuller P, Perros F, Balabanian K, Humbert M. Inflammation in pulmonary arterial hypertension. <i>Eur Respir J<\/i> 2003; 22: 358\u2013363.","DOI":"10.1183\/09031936.03.00038903"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kherbeck N, Tamby MC, Bussone G, Dib H, Perros F, Humbert M, et al. The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension. <i>Clin Rev Allergy Immunol<\/i> 2013; 44: 31\u201338.","DOI":"10.1007\/s12016-011-8265-z"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ciuclan L, Bonneau O, Hussey M, Duggan N, Holmes AM, Good R, et al. A novel murine model of severe pulmonary arterial hypertension. <i>Am J Respir Crit Care Med<\/i> 2011; 184: 1171\u20131782.","DOI":"10.1164\/rccm.201103-0412OC"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Maurer B, Reich N, Juengel A, Kriegsmann J, Gay RE, Schett G, et al. Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis. <i>Ann Rheum Dis<\/i> 2012; 71: 1382\u20131387.","DOI":"10.1136\/annrheumdis-2011-200940"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Biasin V, Marsh LM, Egemnazarov B, Wilhelm J, Ghanim B, Klepetko W, et al. Meprin beta, a novel mediator of vascular remodelling underlying pulmonary hypertension. <i>J Pathol<\/i> 2014; 233: 7\u201317.","DOI":"10.1002\/path.4303"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hoyles RK, Derrett-Smith EC, Khan K, Shiwen X, Howat SL, Wells AU, et al. An essential role for resident fibroblasts in experimental lung fibrosis is defined by lineage-specific deletion of high-affinity type II transforming growth factor beta receptor. <i>Am J Respir Crit Care Med<\/i> 2011; 183: 249\u2013261.","DOI":"10.1164\/rccm.201002-0279OC"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Derrett-Smith EC, Dooley A, Gilbane AJ, Trinder SL, Khan K, Baliga R, et al. Endothelial injury in a transforming growth factor beta-dependent mouse model of scleroderma induces pulmonary arterial hypertension. <i>Arthritis Rheum<\/i> 2013; 65: 2928\u20132939.","DOI":"10.1002\/art.38078"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Sugimoto K, Nakazato K, Sato A, Suzuki S, Yoshihisa A, Machida T, et al. Autoimmune disease mouse model exhibits pulmonary arterial hypertension. <i>PLoS One<\/i> 2017; 12: e0184990.","DOI":"10.1371\/journal.pone.0184990"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Dahlgren J, Takhar H, Anderson-Mahoney P, Kotlerman J, Tarr J, Warshaw R. Cluster of systemic lupus erythematosus (SLE) associated with an oil field waste site: A cross sectional study. <i>Environ Health<\/i> 2007; 6: 8.","DOI":"10.1186\/1476-069X-6-8"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Satoh M, Reeves WH. Induction of lupus-associated autoantibodies in BALB\/c mice by intraperitoneal injection of pristane. <i>J Exp Med<\/i> 1994; 180: 2341\u20132346.","DOI":"10.1084\/jem.180.6.2341"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Anderson PN, Potter M. Induction of plasma cell tumours in BALB-c mice with 2,6,10,14-tetramethylpentadecane (pristane). <i>Nature<\/i> 1969; 222: 994\u2013995.","DOI":"10.1038\/222994a0"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Dedera DA, Urashima M, Chauhan D, LeBrun DP, Bronson RT, Anderson KC. Interleukin-6 is required for pristane-induced plasma cell hyperplasia in mice. <i>Br J Haematol<\/i> 1996; 94: 53\u201361.","DOI":"10.1046\/j.1365-2141.1996.6282074.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Richards HB, Satoh M, Shaw M, Libert C, Poli V, Reeves WH. Interleukin 6 dependence of anti-DNA antibody production: Evidence for two pathways of autoantibody formation in pristane-induced lupus. <i>J Exp Med<\/i> 1998; 188: 985\u2013990.","DOI":"10.1084\/jem.188.5.985"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Chowdhary VR, Grande JP, Luthra HS, David CS. Characterization of haemorrhagic pulmonary capillaritis: Another manifestation of Pristane-induced lupus. <i>Rheumatology (Oxford)<\/i> 2007; 46: 1405\u20131410.","DOI":"10.1093\/rheumatology\/kem117"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Zhuang H, Han S, Lee PY, Khaybullin R, Shumyak S, Lu L, et al. Pathogenesis of diffuse alveolar hemorrhage in murine lupus. <i>Arthritis Rheumatol<\/i> 2017; 69: 1280\u20131293.","DOI":"10.1002\/art.40077"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Sonobe T, Schwenke DO, Pearson JT, Yoshimoto M, Fujii Y, Umetani K, et al. Imaging of the closed-chest mouse pulmonary circulation using synchrotron radiation microangiography. <i>J Appl Physiol (1985)<\/i> 2011; 111: 75\u201380.","DOI":"10.1152\/japplphysiol.00205.2011"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Arita Y, Nakaoka Y, Matsunaga T, Kidoya H, Yamamizu K, Arima Y, et al. Myocardium-derived angiopoietin-1 is essential for coronary vein formation in the developing heart. <i>Nat Commun<\/i> 2014; 5: 4552.","DOI":"10.1038\/ncomms5552"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Barker TT, Lee PY, Kelly-Scumpia KM, Weinstein JS, Nacionales DC, Kumagai Y, et al. Pathogenic role of B cells in the development of diffuse alveolar hemorrhage induced by pristane. <i>Lab Invest<\/i> 2011; 91: 1540\u20131550.","DOI":"10.1038\/labinvest.2011.108"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Fazilleau N, Mark L, McHeyzer-Williams LJ, McHeyzer-Williams MG. Follicular helper T cells: Lineage and location. <i>Immunity<\/i> 2009; 30: 324\u2013335.","DOI":"10.1016\/j.immuni.2009.03.003"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Huang C, Li M, Liu Y, Wang Q, Guo X, Zhao J, et al. Baseline characteristics and risk factors of pulmonary arterial hypertension in systemic lupus erythematosus patients. <i>Medicine (Baltimore)<\/i> 2016; 95: e2761.","DOI":"10.1097\/MD.0000000000002761"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Carlsson H, Westerholm R, \u00d6stman C. Particulate and semivolatile associated aliphatic hydrocarbon exhaust emission from heavy duty diesel vehicles. <i>Toxicol Environ Chem<\/i> 1999; 68: 413\u2013428.","DOI":"10.1080\/02772249909358674"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Park SH, Chen WC, Durmus N, Bleck B, Reibman J, Riemekasten G, et al. The effects of antigen-specific IgG1 antibody for the pulmonary-hypertension-phenotype and B cells for inflammation in mice exposed to antigen and fine particles from air pollution. <i>PLoS One<\/i> 2015; 10: e0129910.","DOI":"10.1371\/journal.pone.0129910"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Liu J, Ye X, Ji D, Zhou X, Qiu C, Liu W, et al. Diesel exhaust inhalation exposure induces pulmonary arterial hypertension in mice. <i>Environ Pollut<\/i> 2018; 237: 747\u2013755.","DOI":"10.1016\/j.envpol.2017.10.121"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Han S, Zhuang H, Xu Y, Lee P, Li Y, Wilson JC, et al. Maintenance of autoantibody production in pristane-induced murine lupus. <i>Arthritis Res Ther<\/i> 2015; 17: 384.","DOI":"10.1186\/s13075-015-0886-9"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Kuroda Y, Akaogi J, Nacionales DC, Wasdo SC, Szabo NJ, Reeves WH, et al. Distinctive patterns of autoimmune response induced by different types of mineral oil. <i>Toxicol Sci<\/i> 2004; 78: 222\u2013228.","DOI":"10.1093\/toxsci\/kfh063"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Reeves WH, Lee PY, Weinstein JS, Satoh M, Lu L. Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. <i>Trends Immunol<\/i> 2009; 30: 455\u2013464.","DOI":"10.1016\/j.it.2009.06.003"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Pugliese SC, Poth JM, Fini MA, Olschewski A, El Kasmi KC, Stenmark KR. The role of inflammation in hypoxic pulmonary hypertension: From cellular mechanisms to clinical phenotypes. <i>Am J Physiol Lung Cell Mol Physiol<\/i> 2015; 308: L229\u2013L252.","DOI":"10.1152\/ajplung.00238.2014"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Craft JE. Follicular helper T cells in immunity and systemic autoimmunity. <i>Nat Rev Rheumatol<\/i> 2012; 8: 337\u2013347.","DOI":"10.1038\/nrrheum.2012.58"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Batten M, Ramamoorthi N, Kljavin NM, Ma CS, Cox JH, Dengler HS, et al. IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells. <i>J Exp Med<\/i> 2010; 207: 2895\u20132906.","DOI":"10.1084\/jem.20100064"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Perros F, Dorfmuller P, Montani D, Hammad H, Waelput W, Girerd B, et al. Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension. <i>Am J Respir Crit Care Med<\/i> 2012; 185: 311\u2013321.","DOI":"10.1164\/rccm.201105-0927OC"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Li S, Xie Q, Zeng Y, Zou C, Liu X, Wu S, et al. A naturally occurring CD8(+)CD122(+) T-cell subset as a memory-like Treg family. <i>Cell Mol Immunol<\/i> 2014; 11: 326\u2013331.","DOI":"10.1038\/cmi.2014.25"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Zhang X, Chang Li X, Xiao X, Sun R, Tian Z, Wei H. CD4(+)CD62L(+) central memory T cells can be converted to Foxp3(+) T cells. <i>PLoS One<\/i> 2013; 8: e77322.","DOI":"10.1371\/journal.pone.0077322"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Ohta-Ogo K, Hao H, Ishibashi-Ueda H, Hirota S, Nakamura K, Ohe T, et al. CD44 expression in plexiform lesions of idiopathic pulmonary arterial hypertension. <i>Pathol Int<\/i> 2012; 62: 219\u2013225.","DOI":"10.1111\/j.1440-1827.2011.02779.x"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Strieter RM, Gomperts BN, Keane MP. The role of CXC chemokines in pulmonary fibrosis. <i>J Clin Invest<\/i> 2007; 117: 549\u2013556.","DOI":"10.1172\/JCI30562"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Keane MP, Belperio JA, Moore TA, Moore BB, Arenberg DA, Smith RE, et al. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. <i>J Immunol<\/i> 1999; 162: 5511\u20135518.","DOI":"10.4049\/jimmunol.162.9.5511"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Grigoryev DN, Mathai SC, Fisher MR, Girgis RE, Zaiman AL, Housten-Harris T, et al. Identification of candidate genes in scleroderma-related pulmonary arterial hypertension. <i>Transl Res<\/i> 2008; 151: 197\u2013207.","DOI":"10.1016\/j.trsl.2007.12.010"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/84\/7\/84_CJ-19-1102\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:47:17Z","timestamp":1696225637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/84\/7\/84_CJ-19-1102\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,25]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-19-1102","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,25]]}}}